novavax ceo stanley erck on the company's covid-19 vaccine
Published 3 years ago • 12K plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
4:46
novavax ceo: we can now make covid vaccine at competitive commercial levels
-
4:12
novavax ceo on the company's phase one australia covid-19 vaccine trial
-
8:45
novavax ceo talks receiving $384 million in cepi funding for coronavirus vaccine candidate
-
6:36
novavax ceo stanley erck| mad money | cnbc
-
5:26
novavax ceo: covid-19 shot could be cleared for the u.s. by may
-
3:45
how novavax -the new protein subunit vaccine- is produced and how it works
-
4:01
man with vaccine side-effect has message for unvaccinated
-
5:25
novavax ceo: biotech bounce back | mad money | cnbc
-
5:15
novavax ceo discusses covid vaccine, which was cleared for use in the eu
-
5:47
novavax ceo on $1.6 billion in federal funding, covid-19 vaccine progress and more
-
2:16
novavax ceo on delayed u.s. covid-19 vaccine trial
-
0:33
covid-19: novavax ceo on what makes their vaccine distribution simpler than others
-
1:02
how the novavax vaccine fared against the omicron variant
-
8:08
novavax ceo on covid vaccine approval, omicron efficacy
-
5:59
novavax ceo: vaccination value | mad money | cnbc
-
2:59
novavax shares drop after report of covid vaccine manufacturing issues
-
4:25
novavax ceo reflects on covid-19, company milestones, and his retirement
-
1:31
coronavirus: novavax gets $1.6 billion in federal funding for covid-19 vaccine development
-
0:43
cdc panel unanimously recommends novavax covid vaccine for adults
-
2:41
novavax interim data shows its covid vaccine is 89% effective in u.k. trial
-
3:27
novavax ceo says company at 'tipping point' with covid-19 vaccine
-
2:59
novavax plans flu/covid vaccine trial in 2021